NCT05054725 2026-01-06Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesRevolution Medicines, Inc.Phase 2 Completed47 enrolled 17 charts
NCT04564027 2025-08-29A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerAstraZenecaPhase 2 Completed54 enrolled 16 charts
NCT02467582 2025-05-16Adjuvant Aspirin Treatment for Colon Cancer PatientsSwiss Cancer InstitutePhase 3 Terminated1,040 enrolled 11 charts